Newtown, PA, United States of America

Joel B Portnoff

This inventor holds 1 USPTO granted patent. Top assignee: Transave Limited. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joel B Portnoff. Retrieved from https://idiyas.com/inventor/joel-b-portnoff-rexmx3nk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Joel B Portnoff

Introduction

Joel B Portnoff is a notable inventor based in Newtown, PA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the inhalation of stable platinum-containing formulations as a method for treating cancers.

Latest Patents

Joel B Portnoff holds 1 patent for his invention titled "Treatment of cancers by inhalation of stable platinum-containing formulations." This patent discloses methods that utilize inhalation techniques to deliver effective cancer treatments, showcasing his commitment to advancing medical science.

Career Highlights

Portnoff is associated with Transave Limited, where he continues to work on groundbreaking research in the medical field. His dedication to innovation has positioned him as a key figure in the development of new therapeutic methods.

Collaborations

Throughout his career, Joel has collaborated with esteemed colleagues such as Frank G Pilkiewicz and Lawrence T Boni. These partnerships have further enhanced his research efforts and contributed to the advancement of cancer treatment methodologies.

Conclusion

Joel B Portnoff's innovative work in cancer treatment exemplifies the impact of dedicated inventors in the medical field. His contributions continue to inspire advancements in therapeutic techniques and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…